Cite
HARVARD Citation
Eley, T. et al. (2015). The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor. Antiviral therapy. 20 (1), pp. 29-37. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Eley, T. et al. (2015). The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor. Antiviral therapy. 20 (1), pp. 29-37. [Online].